Strategies For Phase I Clinical Development, Budget Management, And Service Provider Selection

By: Brandon Allison

Have you ever wondered how your competitors are outsourcing, how that is allocated to different service providers, and how those outsourcing partners are selected? Current and predicted study spending and outsourcing proportions are critical pieces of information that drug sponsors and service providers should be familiar with.

With ISR’s Phase I Market Outlook report, C-level R&D professionals at pharmaceutical companies can get answers to those questions by reviewing survey response data gathered from 125 Phase I decision-makers.

In addition, gain insights on trends such as the use of challenge trials, diagnostic development, and more to stay current with market happenings and plan for market predictions in 2026.